negative symptoms

Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia

Authors: David Walling, Stephen R Marder, John Kane, W Wolfgang Fleischhacker, Richard S E Keefe, David A Hosford, Chris Dvergsten, Anthony C Segreti, Jessica S Beaver, Steven M Toler, John E Jett, Geoffrey C Dunbar

Journal: Schizophrenia Bulletin

Year Published: 2015

Objectives: This trial was conducted to test the effects of an alpha7 nicotinic receptor full agonist, TC-5619, on negative and cognitive symptoms in subjects with schizophrenia. Methods: In 64 sites in the United States, Russia, Ukraine, […]

Back to Publications

Cogstate
© 2024 Cogstate Ltd.

Cogstate acknowledges Aboriginal and Torres Strait Islander people as the Traditional Custodians of the lands where many of our team members live and work. We pay respect to their Elders past and present.